Incyte earnings forcast
WebForecasts Financials Shareholders Competitors Stock Price Forecast The 16 analysts offering 12-month price forecasts for Incyte Corp have a median target of 88.50, with a … WebApr 3, 2024 · Incyte (INCY) stock forecast for 2024 Last update: March 13, 2024 (06:06) Sector: Healthcare The share price of Incyte Corp. (INCY) now Incyte Corporation 73.62 D 0.47% (0.35) What analysts predict: $89.38 52-week High/Low: $86.29 / $65.07 50/200 Day Moving Average: $80.09 / $76.16
Incyte earnings forcast
Did you know?
WebApr 11, 2024 · According to the current price, Incyte is 87.55% away from the 52-week high. What are analysts forecasts for Incyte stock? The 39 analysts offering price forecasts for Incyte have a... WebApr 15, 2024 · Incyte's quarterly revenue was up 7.4% on a year-over-year basis. On average, sell-side analysts forecast that Incyte Co. will post 3.29 earnings per share for the current year. Incyte Profile . Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics.
WebTOMORROW’S WEATHER FORECAST. 4/13. 80° / 56°. RealFeel® 80°. Mostly sunny. WebApr 3, 2024 · We forecast Incyte stock performance using neural networks based on historical data on Incyte stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. ... It uses the current share price and divides it by the total earnings per share for the last 12 months. Forward PE: 14.95
WebApr 13, 2024 · The company has a market cap of $16.49 billion, a price-to-earnings ratio of 48.65, a P/E/G ratio of 3.28 and a beta of 0.73. Incyte Co. has a twelve month low of $65.07 and a twelve month high of ... WebFeb 8, 2024 · Incyte ( NASDAQ:INCY) Full Year 2024 Results Key Financial Results Revenue: US$3.39b (up 14% from FY 2024). Net income: US$340.7m (down 64% from FY 2024). Profit margin: 10.0% (down from 32% in...
WebApr 12, 2024 · Incyte ( NASDAQ:INCY – Get Rating) last released its earnings results on Tuesday, February 7th. The biopharmaceutical company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. Incyte had a return on equity of 11.45% and a net margin of 10.03%.
WebApr 12, 2024 · INCY: Incyte Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. INCY: Incyte - Detailed Earnings Estimates - Zacks.com dickinson foods idahoWebFeb 7, 2024 · Incyte (INCY) Earnings Dates & Reports On this page, you can find detailed information about the financial performance of Incyte, including the latest Incyte earnings … dickinson foods fruitland idahoWebMar 20, 2024 · See the latest earnings results for INCY. Explore Incyte Corp.'s earnings history, its beat/miss ratio and outlook for next earnings reports. citric thermalWebJul 30, 2024 · For its second quarter ended June 30, Incyte earnings were 75 cents per share, minus some items. On a year-over-year basis, Incyte earnings popped 19%. That … dickinson food stampsWebApr 10, 2024 · Incyte is forecasted to grow earnings and revenue by 29.0% and 10.6% per annum respectively. EPS and ROE are also expected to grow by 28.0% and 20.0% per year … dickinson fmoviesWebApr 11, 2024 · Incyte (NASDAQ:INCY) has a market capitalization of $16.54 billion and generates $3.39 billion in revenue each year. The biopharmaceutical company earns … citrin cooperman rhode islandWebThe 16 analysts offering 12-month price forecasts for Incyte Corp have a median target of 88.50, with a high estimate of 118.00 and a low estimate of 61.00. The median estimate represents a... citrine and abundance